NCT05956002 A Study to Evaluate the Study Medication (Etrasimod) When Mixed With Food in Healthy Participants Status COMPLETED Phase PHASE1
NCT05954546 A Study to Compare How Effective is Encorafenib Plus Binimetinib in Real-world and Clinical Trial Settings Status COMPLETED Phase N/A
NCT05948462 Lorlatinib in Combination With Chemotherapy in Participants With Metastatic Anaplastic Lymphoma Kinase Positive (ALK+) Non-small Cell Lung Cancer (NSCLC) Who Progressed on Single-agent Lorlatinib Status WITHDRAWN Phase PHASE2
NCT05948085 A Study to Compare Zavegepant Concentration Using Samples Collected From the Vein Versus Patient-Centric Microsampling Status COMPLETED Phase PHASE1
NCT05935748 Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc) Status TERMINATED Phase PHASE2
NCT05932290 A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma Status COMPLETED Phase N/A
NCT05930925 A Study to Understand How the Study Medicine Called ARV-471 is Processed in Healthy Adults Status COMPLETED Phase PHASE1
NCT05926960 A Study Comparing 3 Study Medicines (Encorafenib, Binimetinib, Pembrolizumab) to 2 Study Medicines (Ipilimumab and Nivolumab) in Patients With Advanced Melanoma Status TERMINATED Phase PHASE2
NCT05923411 A Study for Multiple Tablet Forms of The Study Medicine (PF-07220060) in Healthy Adults Status COMPLETED Phase PHASE1
NCT05912933 A Study to Learn About the Relationship Between Hepatic Impairment and Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal-bow-sai-klib) Status COMPLETED Phase N/A
NCT05909397 Vepdegestrant (ARV-471/PF-07850327) + Palbociclib vs Letrozole + Palbociclib in ER(+)/HER2(-) Advanced Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05907395 A Study to Learn About the Study Medicine (PF-07293893) at Different Dose Levels in Healthy Adults Status COMPLETED Phase PHASE1
NCT05905341 Study of PF-07224826, as a Single Agent or in Combination With Endocrine Therapy in Participants With Breast Cancer and Other Advanced Solid Tumors. Status WITHDRAWN Phase PHASE1
NCT05900154 A Study to Learn About the Safety and Immune Activity of RSVpreF in Children 2 to <18 Years of Age Status COMPLETED Phase PHASE1
NCT05898672 A Study to Learn About the Study Medicine Called Nirmatrelvir/Ritonavir in People Who Are Healthy Volunteers Co-administered the Medicine Rosuvastatin Status COMPLETED Phase PHASE1
NCT05896774 A Study to Learn About the Study Medicine (Maplirpacept) in People With Advanced Non-Hodgkin Lymphoma or Multiple Myeloma in China Status COMPLETED Phase PHASE1
NCT05896163 A Study to Learn About the Effects of Two Study Medicines (Maplirpacept [PF-07901801] And Glofitamab) When Given Together In People With Relapsed Or Refractory Diffuse Large B Cell Lymphoma. Status TERMINATED Phase PHASE1/PHASE2
NCT05895786 A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)] Status RECRUITING Phase PHASE3